Vogenx 

€18.14
1
+€0.08+0.44% 07:06 Today

Statistics

Day High
18.14
Day Low
18.14
52W High
31
52W Low
12.88
Volume
-
Avg. Volume
-
Mkt Cap
269.47M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 2Expected
Q2 2026
Next
-0.08
-0.07
-0.07
-0.06
Expected EPS
-0.0806715
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2024
2025
0Revenue
-1.23MNet Income

Analyst Ratings

$36.80Average Price Target
The highest estimate is ⁦41.73⁩.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.
Show More
CEO
James Green
Employees
5
Country
Canada
ISIN
US92859A1060
WKN
000A42HLK

Listings

0 Comments

Share your thoughts

FAQs

What is Vogenx stock price today?▼
The current price of 1Q8.F is €18.14 EUR — it has increased by +0.44% in the past 24 hours. Watch Vogenx stock price performance more closely on the chart.
What is Vogenx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Vogenx stocks are traded under the ticker 1Q8.F.
What is Vogenx market cap?▼
Today Vogenx has the market capitalization of 269.47M
When is the next Vogenx earnings date?▼
Vogenx is going to release the next earnings report on December 2, 2026.
What were Vogenx earnings last quarter?▼
1Q8.F earnings for the last quarter are -0.07 EUR per share, whereas the estimation was -0.06 EUR resulting in a -21.43% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Vogenx revenue for the last year?▼
Vogenx revenue for the last year amounts to 0 EUR.
What is Vogenx net income for the last year?▼
1Q8.F net income for the last year is -1.23M EUR.
How many employees does Vogenx have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Vogenx located?▼
Vogenx operates in the Health & Wellness sector.
When did Vogenx complete a stock split?▼
Vogenx has not had any recent stock splits.
Where is Vogenx headquartered?▼
Vogenx is headquartered in RALEIGH, Canada.